Forest Laboratories

Market Wrap For May 14: Dow's Winning Streak Ends At Five Sessions

Market Wrap For April 30: Markets Positive Despite Fed Tapering and GDP Rising Less Than Expected

Market Wrap For April 28: Apple Hits New 52-Week Highs In a Volatile Start To the Trading Week

Market Wrap For April 30: Markets Positive Despite Fed Tapering and GDP Rising Less Than Expected

Market Wrap For April 28: Apple Hits New 52-Week Highs In a Volatile Start To the Trading Week

Sterne Agee Sees 16% Upside for Actavis, Initiates Coverage

Mergers And Acquisitions In 2014 (Thus Far)

Sterne Agee Sees 16% Upside for Actavis, Initiates Coverage

Mergers And Acquisitions In 2014 (Thus Far)

Market Wrap For Febuary 20: S&P 500 Inches Closer To New Highs

Market Wrap For February 19: Stocks Close Lower, Nasdaq Ends Winning Streak

Forest Laboratories Recent News

Market Wrap For February 18: Dow Finishes Lower, Nasdaq Still Hot

Top Trending Tickers On StockTwits For February 18

Market Wrap For January 8: Fed Minutes Released

Barron's Recap (3/23/13): World's Best CEOs

Goldman Sachs and Others That May Beat Earnings

Earnings Expectations for the Week of October 15

UPDATE: Citadel Initiates Coverage on Forest Laboratories

Forest Labs and Watson Pharma to Open Near 52-Week Highs

UPDATE: Duncan-Williams Color on Forest Laboratories PT Increase

Duncan Williams Raises PT On Forest Laboratories To $45

Colgate and Forest Labs to Open Near 52-Week Highs

Goldman Sachs Maintains Neutral Rating On Forest Laboratories

CIGNA and Forest Laboratories Open Near 52-Week Highs

J.P. Morgan Maintains Overweight on Forest Laboratories

Ten More Takeover Candidates

UPDATE: J.P. Morgan Upgrades Forest Laboratories to Overweight

JP Morgan Upgrades Forest Laboratories To Overweight, PT Raised To $41

UPDATE: Jefferies Color On Forest Laboratories PT Increase

Jefferies Raises PT On Forest Labs To $42

Piper Jaffray Lowers PT On Forest Laboratories To $29

Citi Comments On FRX Core Product And Pricing Trends

Jefferies Sees No Value Destruction To Forest Laboratories

Oppenheimer Adjusts FRX Estimates Following CLDA Acquisition Announcement